Loading…
Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block
Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1....
Saved in:
Published in: | Journal of Pharmacological Sciences 2008, Vol.108(1), pp.49-55 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143 |
---|---|
cites | cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143 |
container_end_page | 55 |
container_issue | 1 |
container_start_page | 49 |
container_title | Journal of Pharmacological Sciences |
container_volume | 108 |
creator | Aréchiga, Iván A. Barrio-Echavarria, Gabriel F. Rodríguez-Menchaca, Aldo A. Moreno-Galindo, Eloy G. Decher, Niels Tristani-Firouzi, Martin Sánchez-Chapula, José A. Navarro-Polanco, Ricardo A. |
description | Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon. |
doi_str_mv | 10.1254/jphs.08084FP |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1347861319313738</els_id><doaj_id>oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81</doaj_id><sourcerecordid>18818480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</originalsourceid><addsrcrecordid>eNptkcGO0zAQhiMEYpeFG2fkB6BdT-IkDrelpeyKRcsBztbUnjQOiRPZ6Up9e9ymlAsHjy3P729mfifJe-BLSHNx245NWHLJpdj8eJFcQybKhSyEfHk5Q3aVvAmh5TyVHIrXyRVICVJIfp3gt2dY5uxpJMdWDTpHHfvcDfo32x7Y1BC7c5NF75vD1PRWs7Xf79jahmE8eOytoU_s-9CR3nfo2Zom8r116KbAhnoGvU1e1dgFenfeb5Jfmy8_V_eLx6evD6u7x4UuIZ0WKLgRgpe1EWBKMCLNamOK3JCUFRaG6tJwBNQIYPKs1lVGeQWQiywzBkR2kzzMXDNgq0Zve_QHNaBVp4vB7xT6yeqOFKEpTUrbkh_roKnygrLSFHVWCjISIuvjzNJ-CMFTfeEBV0fX1dF1dXY9yj_M8nG_7cn8E59tjoLNLIhZq7EbXGcdqXbYexc9UbougrbkVMq5VBwiGBTnRVyiiiHPJU-5kBG0nkFtmHBHl0p_Jzu1FZ8rOMVzg5e0btArchFTzBiKH_JsyatTeR2786Sn6Jj9_6R_AC5vvzs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><source>ScienceDirect Journals</source><creator>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A.</creator><creatorcontrib>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A. ; Department of Pediatric of Cardiology ; University of Utah ; Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima ; Philipps-University ; Institute of Physiology</creatorcontrib><description>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</description><identifier>ISSN: 1347-8613</identifier><identifier>EISSN: 1347-8648</identifier><identifier>DOI: 10.1254/jphs.08084FP</identifier><identifier>PMID: 18818480</identifier><language>eng</language><publisher>Japan: Elsevier B.V</publisher><subject>Alanine - genetics ; Anti-Arrhythmia Agents - pharmacology ; antiarrhythmic ; Cell Line ; Data Interpretation, Statistical ; disopyramide ; Disopyramide - pharmacology ; Humans ; Kv1.5 ; Kv1.5 Potassium Channel - chemistry ; Kv1.5 Potassium Channel - drug effects ; Kv1.5 Potassium Channel - genetics ; Mutagenesis - drug effects ; Patch-Clamp Techniques ; potassium channel ; Potassium Channel Blockers ; ultra rapid delayed rectifier</subject><ispartof>Journal of Pharmacological Sciences, 2008, Vol.108(1), pp.49-55</ispartof><rights>2008 Elsevier B.V.</rights><rights>The Japanese Pharmacological Society 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</citedby><cites>FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1347861319313738$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,4024,27923,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18818480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aréchiga, Iván A.</creatorcontrib><creatorcontrib>Barrio-Echavarria, Gabriel F.</creatorcontrib><creatorcontrib>Rodríguez-Menchaca, Aldo A.</creatorcontrib><creatorcontrib>Moreno-Galindo, Eloy G.</creatorcontrib><creatorcontrib>Decher, Niels</creatorcontrib><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Sánchez-Chapula, José A.</creatorcontrib><creatorcontrib>Navarro-Polanco, Ricardo A.</creatorcontrib><creatorcontrib>Department of Pediatric of Cardiology</creatorcontrib><creatorcontrib>University of Utah</creatorcontrib><creatorcontrib>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</creatorcontrib><creatorcontrib>Philipps-University</creatorcontrib><creatorcontrib>Institute of Physiology</creatorcontrib><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><title>Journal of Pharmacological Sciences</title><addtitle>J Pharmacol Sci</addtitle><description>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</description><subject>Alanine - genetics</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>antiarrhythmic</subject><subject>Cell Line</subject><subject>Data Interpretation, Statistical</subject><subject>disopyramide</subject><subject>Disopyramide - pharmacology</subject><subject>Humans</subject><subject>Kv1.5</subject><subject>Kv1.5 Potassium Channel - chemistry</subject><subject>Kv1.5 Potassium Channel - drug effects</subject><subject>Kv1.5 Potassium Channel - genetics</subject><subject>Mutagenesis - drug effects</subject><subject>Patch-Clamp Techniques</subject><subject>potassium channel</subject><subject>Potassium Channel Blockers</subject><subject>ultra rapid delayed rectifier</subject><issn>1347-8613</issn><issn>1347-8648</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkcGO0zAQhiMEYpeFG2fkB6BdT-IkDrelpeyKRcsBztbUnjQOiRPZ6Up9e9ymlAsHjy3P729mfifJe-BLSHNx245NWHLJpdj8eJFcQybKhSyEfHk5Q3aVvAmh5TyVHIrXyRVICVJIfp3gt2dY5uxpJMdWDTpHHfvcDfo32x7Y1BC7c5NF75vD1PRWs7Xf79jahmE8eOytoU_s-9CR3nfo2Zom8r116KbAhnoGvU1e1dgFenfeb5Jfmy8_V_eLx6evD6u7x4UuIZ0WKLgRgpe1EWBKMCLNamOK3JCUFRaG6tJwBNQIYPKs1lVGeQWQiywzBkR2kzzMXDNgq0Zve_QHNaBVp4vB7xT6yeqOFKEpTUrbkh_roKnygrLSFHVWCjISIuvjzNJ-CMFTfeEBV0fX1dF1dXY9yj_M8nG_7cn8E59tjoLNLIhZq7EbXGcdqXbYexc9UbougrbkVMq5VBwiGBTnRVyiiiHPJU-5kBG0nkFtmHBHl0p_Jzu1FZ8rOMVzg5e0btArchFTzBiKH_JsyatTeR2786Sn6Jj9_6R_AC5vvzs</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Aréchiga, Iván A.</creator><creator>Barrio-Echavarria, Gabriel F.</creator><creator>Rodríguez-Menchaca, Aldo A.</creator><creator>Moreno-Galindo, Eloy G.</creator><creator>Decher, Niels</creator><creator>Tristani-Firouzi, Martin</creator><creator>Sánchez-Chapula, José A.</creator><creator>Navarro-Polanco, Ricardo A.</creator><general>Elsevier B.V</general><general>The Japanese Pharmacological Society</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>2008</creationdate><title>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</title><author>Aréchiga, Iván A. ; Barrio-Echavarria, Gabriel F. ; Rodríguez-Menchaca, Aldo A. ; Moreno-Galindo, Eloy G. ; Decher, Niels ; Tristani-Firouzi, Martin ; Sánchez-Chapula, José A. ; Navarro-Polanco, Ricardo A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Alanine - genetics</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>antiarrhythmic</topic><topic>Cell Line</topic><topic>Data Interpretation, Statistical</topic><topic>disopyramide</topic><topic>Disopyramide - pharmacology</topic><topic>Humans</topic><topic>Kv1.5</topic><topic>Kv1.5 Potassium Channel - chemistry</topic><topic>Kv1.5 Potassium Channel - drug effects</topic><topic>Kv1.5 Potassium Channel - genetics</topic><topic>Mutagenesis - drug effects</topic><topic>Patch-Clamp Techniques</topic><topic>potassium channel</topic><topic>Potassium Channel Blockers</topic><topic>ultra rapid delayed rectifier</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aréchiga, Iván A.</creatorcontrib><creatorcontrib>Barrio-Echavarria, Gabriel F.</creatorcontrib><creatorcontrib>Rodríguez-Menchaca, Aldo A.</creatorcontrib><creatorcontrib>Moreno-Galindo, Eloy G.</creatorcontrib><creatorcontrib>Decher, Niels</creatorcontrib><creatorcontrib>Tristani-Firouzi, Martin</creatorcontrib><creatorcontrib>Sánchez-Chapula, José A.</creatorcontrib><creatorcontrib>Navarro-Polanco, Ricardo A.</creatorcontrib><creatorcontrib>Department of Pediatric of Cardiology</creatorcontrib><creatorcontrib>University of Utah</creatorcontrib><creatorcontrib>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</creatorcontrib><creatorcontrib>Philipps-University</creatorcontrib><creatorcontrib>Institute of Physiology</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of Pharmacological Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aréchiga, Iván A.</au><au>Barrio-Echavarria, Gabriel F.</au><au>Rodríguez-Menchaca, Aldo A.</au><au>Moreno-Galindo, Eloy G.</au><au>Decher, Niels</au><au>Tristani-Firouzi, Martin</au><au>Sánchez-Chapula, José A.</au><au>Navarro-Polanco, Ricardo A.</au><aucorp>Department of Pediatric of Cardiology</aucorp><aucorp>University of Utah</aucorp><aucorp>Unidad de Investigacion“Carlos Mendez”del Centro de Investigaciones Biomedicas de la Universidad de Colima</aucorp><aucorp>Philipps-University</aucorp><aucorp>Institute of Physiology</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block</atitle><jtitle>Journal of Pharmacological Sciences</jtitle><addtitle>J Pharmacol Sci</addtitle><date>2008</date><risdate>2008</risdate><volume>108</volume><issue>1</issue><spage>49</spage><epage>55</epage><pages>49-55</pages><issn>1347-8613</issn><eissn>1347-8648</eissn><abstract>Kv1.5 is considered to be a potential molecular target for treatment of atrial fibrillation or flutter. Disopyramide is widely used in the treatment of atrial flutter and/or atrial fibrillation. The present study was undertaken to characterize the effects of disopyramide on currents mediated by Kv1.5 channels and to determine the putative binding site involved in the inhibitory effects of disopyramide. Experiments were carried out on wild-type and site directed mutated hKv1.5 channels expressed on HEK 293 cells using the patch-clamp technique. Disopyramide acting from the cytoplasmic side of the membrane produced blocking effects on Kv1.5 that exhibited several features typical of an open channel blocker. Ala-scanning mutagenesis of the Kv1.5 pore domain combined with macroscopic current analysis suggested that disopyramide interacted only with the Val512 residue that faces to the central cavity of the channel. Mutation of this key residue to Ala caused marked change in the IC50 of disopyramide (22-fold). The single interaction between disopyramide and Val512 in the PVP region is able to change the mechanism of channel closure, reproducing the “foot-in-the-door” phenomenon.</abstract><cop>Japan</cop><pub>Elsevier B.V</pub><pmid>18818480</pmid><doi>10.1254/jphs.08084FP</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1347-8613 |
ispartof | Journal of Pharmacological Sciences, 2008, Vol.108(1), pp.49-55 |
issn | 1347-8613 1347-8648 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_ead7d2eb701d42ad956e37d6f374ed81 |
source | ScienceDirect Journals |
subjects | Alanine - genetics Anti-Arrhythmia Agents - pharmacology antiarrhythmic Cell Line Data Interpretation, Statistical disopyramide Disopyramide - pharmacology Humans Kv1.5 Kv1.5 Potassium Channel - chemistry Kv1.5 Potassium Channel - drug effects Kv1.5 Potassium Channel - genetics Mutagenesis - drug effects Patch-Clamp Techniques potassium channel Potassium Channel Blockers ultra rapid delayed rectifier |
title | Kv1.5 Open Channel Block by the Antiarrhythmic Drug Disopyramide: Molecular Determinants of Block |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kv1.5%20Open%20Channel%20Block%20by%20the%20Antiarrhythmic%20Drug%20Disopyramide:%20Molecular%20Determinants%20of%20Block&rft.jtitle=Journal%20of%20Pharmacological%20Sciences&rft.au=Ar%C3%A9chiga,%20Iv%C3%A1n%20A.&rft.aucorp=Department%20of%20Pediatric%20of%20Cardiology&rft.date=2008&rft.volume=108&rft.issue=1&rft.spage=49&rft.epage=55&rft.pages=49-55&rft.issn=1347-8613&rft.eissn=1347-8648&rft_id=info:doi/10.1254/jphs.08084FP&rft_dat=%3Cpubmed_doaj_%3E18818480%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c712t-a40d4407fd41d71d423fdd65de889a6def7d0a1aca11d53fc93e59115433dd143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18818480&rfr_iscdi=true |